Fig. 3From: Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnosticsStacked bar chart of monthly number of new variant curations per sample by analysis group and assay type (3Â month rolling average). Hybrid capture technology assays were introduced at the start of 2017 (pale segments). Somatic hybrid capture variants (pink segments) dominate the reporting volume from 2017 onwards and are increasingBack to article page